5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PRASIT, PETPIBOON, PEPPI HUTCHINSON, JOHN, HOWARD STOCK, NICHOLAS, SIMON SEIDERS, THOMAS, JON TRUONG, YEN, PHAM ARRUDA, JEANNIE, M LI, YIWEI HADDACH, MUSTAPHA MORAN, MARK ZUNIC, JASMINE, ELEANOR STEARNS, BRIAN, ANDREW ROPPE, JEFFREY, ROGER EVANS, JILLIAN, F WANG, BOWEI SCOTT, JILL, MELISSA |
| description | Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.Fig. 15 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SG185872A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SG185872A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SG185872A13</originalsourceid><addsrcrecordid>eNrjZDA21fXxDPCPiHR39XMMdtV1dA7xDHMM8fRzVwgI8g9x9fRT0HDzcQzQVPD08_B08gzxDwrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxwe6GFqYW5kaOhsaEVQAAEDcmaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><source>esp@cenet</source><creator>PRASIT, PETPIBOON, PEPPI ; HUTCHINSON, JOHN, HOWARD ; STOCK, NICHOLAS, SIMON ; SEIDERS, THOMAS, JON ; TRUONG, YEN, PHAM ; ARRUDA, JEANNIE, M ; LI, YIWEI ; HADDACH, MUSTAPHA ; MORAN, MARK ; ZUNIC, JASMINE, ELEANOR ; STEARNS, BRIAN, ANDREW ; ROPPE, JEFFREY, ROGER ; EVANS, JILLIAN, F ; WANG, BOWEI ; SCOTT, JILL, MELISSA</creator><creatorcontrib>PRASIT, PETPIBOON, PEPPI ; HUTCHINSON, JOHN, HOWARD ; STOCK, NICHOLAS, SIMON ; SEIDERS, THOMAS, JON ; TRUONG, YEN, PHAM ; ARRUDA, JEANNIE, M ; LI, YIWEI ; HADDACH, MUSTAPHA ; MORAN, MARK ; ZUNIC, JASMINE, ELEANOR ; STEARNS, BRIAN, ANDREW ; ROPPE, JEFFREY, ROGER ; EVANS, JILLIAN, F ; WANG, BOWEI ; SCOTT, JILL, MELISSA</creatorcontrib><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.Fig. 15</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121228&DB=EPODOC&CC=SG&NR=185872A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121228&DB=EPODOC&CC=SG&NR=185872A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PRASIT, PETPIBOON, PEPPI</creatorcontrib><creatorcontrib>HUTCHINSON, JOHN, HOWARD</creatorcontrib><creatorcontrib>STOCK, NICHOLAS, SIMON</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, JON</creatorcontrib><creatorcontrib>TRUONG, YEN, PHAM</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>LI, YIWEI</creatorcontrib><creatorcontrib>HADDACH, MUSTAPHA</creatorcontrib><creatorcontrib>MORAN, MARK</creatorcontrib><creatorcontrib>ZUNIC, JASMINE, ELEANOR</creatorcontrib><creatorcontrib>STEARNS, BRIAN, ANDREW</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, ROGER</creatorcontrib><creatorcontrib>EVANS, JILLIAN, F</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><creatorcontrib>SCOTT, JILL, MELISSA</creatorcontrib><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><description>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.Fig. 15</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDA21fXxDPCPiHR39XMMdtV1dA7xDHMM8fRzVwgI8g9x9fRT0HDzcQzQVPD08_B08gzxDwrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxwe6GFqYW5kaOhsaEVQAAEDcmaQ</recordid><startdate>20121228</startdate><enddate>20121228</enddate><creator>PRASIT, PETPIBOON, PEPPI</creator><creator>HUTCHINSON, JOHN, HOWARD</creator><creator>STOCK, NICHOLAS, SIMON</creator><creator>SEIDERS, THOMAS, JON</creator><creator>TRUONG, YEN, PHAM</creator><creator>ARRUDA, JEANNIE, M</creator><creator>LI, YIWEI</creator><creator>HADDACH, MUSTAPHA</creator><creator>MORAN, MARK</creator><creator>ZUNIC, JASMINE, ELEANOR</creator><creator>STEARNS, BRIAN, ANDREW</creator><creator>ROPPE, JEFFREY, ROGER</creator><creator>EVANS, JILLIAN, F</creator><creator>WANG, BOWEI</creator><creator>SCOTT, JILL, MELISSA</creator><scope>EVB</scope></search><sort><creationdate>20121228</creationdate><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><author>PRASIT, PETPIBOON, PEPPI ; HUTCHINSON, JOHN, HOWARD ; STOCK, NICHOLAS, SIMON ; SEIDERS, THOMAS, JON ; TRUONG, YEN, PHAM ; ARRUDA, JEANNIE, M ; LI, YIWEI ; HADDACH, MUSTAPHA ; MORAN, MARK ; ZUNIC, JASMINE, ELEANOR ; STEARNS, BRIAN, ANDREW ; ROPPE, JEFFREY, ROGER ; EVANS, JILLIAN, F ; WANG, BOWEI ; SCOTT, JILL, MELISSA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SG185872A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>PRASIT, PETPIBOON, PEPPI</creatorcontrib><creatorcontrib>HUTCHINSON, JOHN, HOWARD</creatorcontrib><creatorcontrib>STOCK, NICHOLAS, SIMON</creatorcontrib><creatorcontrib>SEIDERS, THOMAS, JON</creatorcontrib><creatorcontrib>TRUONG, YEN, PHAM</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE, M</creatorcontrib><creatorcontrib>LI, YIWEI</creatorcontrib><creatorcontrib>HADDACH, MUSTAPHA</creatorcontrib><creatorcontrib>MORAN, MARK</creatorcontrib><creatorcontrib>ZUNIC, JASMINE, ELEANOR</creatorcontrib><creatorcontrib>STEARNS, BRIAN, ANDREW</creatorcontrib><creatorcontrib>ROPPE, JEFFREY, ROGER</creatorcontrib><creatorcontrib>EVANS, JILLIAN, F</creatorcontrib><creatorcontrib>WANG, BOWEI</creatorcontrib><creatorcontrib>SCOTT, JILL, MELISSA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PRASIT, PETPIBOON, PEPPI</au><au>HUTCHINSON, JOHN, HOWARD</au><au>STOCK, NICHOLAS, SIMON</au><au>SEIDERS, THOMAS, JON</au><au>TRUONG, YEN, PHAM</au><au>ARRUDA, JEANNIE, M</au><au>LI, YIWEI</au><au>HADDACH, MUSTAPHA</au><au>MORAN, MARK</au><au>ZUNIC, JASMINE, ELEANOR</au><au>STEARNS, BRIAN, ANDREW</au><au>ROPPE, JEFFREY, ROGER</au><au>EVANS, JILLIAN, F</au><au>WANG, BOWEI</au><au>SCOTT, JILL, MELISSA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS</title><date>2012-12-28</date><risdate>2012</risdate><abstract>Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.Fig. 15</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_SG185872A1 |
| source | esp@cenet |
| title | 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A15%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PRASIT,%20PETPIBOON,%20PEPPI&rft.date=2012-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESG185872A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |